(Q43705480)
Statements
1 reference
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure (English)
1 reference
Torre-Amione G
1 reference
Durand JB
1 reference
Nagueh S
1 reference
Vooletich MT
1 reference
Kobrin I
1 reference
Pratt C
1 reference
1 August 2001
1 reference
1 reference
120
1 reference
2
1 reference
460-466
1 reference
Identifiers
1 reference
1 reference